Dupilumab Subcutaneous and Trazodone Extended-Release Tablets
Determining the interaction of Dupilumab Subcutaneous and Trazodone Extended-Release Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: dupilumab
Brand name: Dupixent
Synonyms: Dupilumab
Generic Name: trazodone
Brand name: Desyrel, Desyrel Dividose, Oleptro
Synonyms: Trazodone, TraZODone
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Dupilumab Subcutaneous-Trazodone Hydrochloride
- Dupilumab Subcutaneous-Trazodone Oral
- Dupilumab Subcutaneous-Trazodone Tablets
- Dupilumab Subcutaneous-Treanda
- Dupilumab Subcutaneous-Trecator
- Dupilumab Subcutaneous-Trecator-SC
- Trazodone Extended-Release Tablets-Dupixent
- Trazodone Extended-Release Tablets-Duplex T Topical
- Trazodone Extended-Release Tablets-Durachol
- Trazodone Extended-Release Tablets-Duraclon
- Trazodone Extended-Release Tablets-Duraclon injection
- Trazodone Extended-Release Tablets-Duraflu